Pancreatic Cancer Research

ResearcherUniversity of MiamiActive in the last 2 years

Haleh Amirian

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6094-1342; OpenAlex author ID A5087305318. Sources: OpenAlex.

Their work

Papers
13 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
53
Papers, trials and grants by year

2022: 2 papers · 2023: 1 paper · 2024: 4 papers · 2025: 3 papers · 2026: 3 papers

Papers 13

  1. IL1RAP-expressing myeloid-stromal networks represent a therapeutic vulnerability to improve chemoimmunotherapy sensitivity in pancreatic cancer. Co-author DOI 10.1172/jci.insight.202487↗
  2. Benefit of Adjuvant Therapy After Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-analysis. Co-author DOI 10.1245/s10434-026-19841-5↗
  3. ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic Cancer: A Systematic Review and Meta-anal… Co-author DOI 10.1245/s10434-026-19926-1↗
  4. Cell-specific nanoengineering strategy to disrupt tolerogenic signaling from myeloid-derived suppressor cells and invigorate antitumor immunity in pancreatic c… Co-author DOI 10.1007/s00262-025-04096-y↗
  5. CREB Drives Acinar to Ductal Cells Reprogramming and Promotes Pancreatic Cancer Progression in Preclinical Models of Alcoholic Pancreatitis. Co-author DOI 10.1016/j.jcmgh.2025.101606↗
  6. Targeting CREB remodels the immune microenvironment to enhance immunotherapy responses in pancreatic cancer Co-author DOI 10.64898/2025.12.04.691935↗
  7. Lymph node metrics following neoadjuvant therapy to refine patient selection for adjuvant chemotherapy in resected pancreatic cancer: A multi-institutional ana… Co-author DOI 10.1002/jso.27798↗
  8. Transmembrane TNF-TNFR2 signaling as a critical immunoregulatory node in pancreatic cancer. Co-author DOI 10.1080/2162402x.2024.2326694↗
  9. Tumor Cell-Intrinsic p38 MAPK Signaling Promotes IL1α-Mediated Stromal Inflammation and Therapeutic Resistance in Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-23-1200↗
  10. Improving patient stratification and selection for curative-intent treatment in localized pancreatic cancer. First author DOI 10.21037/hbsn-23-668↗
  11. Cell-Autonomous Cxcl1 Sustains Tolerogenic Circuitries and Stromal Inflammation via Neutrophil-Derived TNF in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-22-1046↗
  12. Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Difference? Co-author DOI 10.1053/j.gastro.2021.12.256↗
  13. Identification of novel early pancreatic cancer biomarkers KIF5B and SFRP2 from "first contact" interactions in the tumor microenvironment. Co-author DOI 10.1186/s13046-022-02425-y↗

Closest collaborators

The 25 strongest of 53 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nipun B. Merchant · 8 shared papers, 2023–2026 · strength 1.55
  2. Jashodeep Datta · 6 shared papers, 2023–2026 · strength 1.30
  3. Anna Bianchi · 5 shared papers, 2023–2026 · strength 1.00
  4. Jashodeep Datta · 5 shared papers, 2024–2025 · strength 0.99
  5. Siddharth Mehra · 5 shared papers, 2023–2025 · strength 0.91
  6. Nagaraj S. Nagathihalli · 5 shared papers, 2023–2025 · strength 0.91
  7. Erin M. Dickey · 4 shared papers, 2024–2026 · strength 0.89
  8. Peter J. Hosein · 3 shared papers, 2024–2026 · strength 0.72
  9. Iago De Castro Silva · 4 shared papers, 2023–2025 · strength 0.72
  10. Austin R. Dosch · 4 shared papers, 2023–2025 · strength 0.69
  11. Ifeanyichukwu Chinedu Ogobuiro · 3 shared papers, 2023–2025 · strength 0.50
  12. Samara P. Singh · 3 shared papers, 2023–2025 · strength 0.50
  13. Bradley Norman Reames · 2 shared papers, 2026 · strength 0.50
  14. José Oberholzer · 2 shared papers, 2026 · strength 0.50
  15. Ning Pu · 2 shared papers, 2026 · strength 0.50
  16. Chunmeng Zhang · 2 shared papers, 2026 · strength 0.50
  17. Dilmurodjon Eshmuminov · 2 shared papers, 2026 · strength 0.50
  18. Víctor López‐López · 2 shared papers, 2026 · strength 0.50
  19. Michael C. Frey · 2 shared papers, 2026 · strength 0.50
  20. So Heun Lee · 2 shared papers, 2026 · strength 0.50
  21. Ralph Fritsch · 2 shared papers, 2026 · strength 0.50
  22. Changhoon Yoo · 2 shared papers, 2026 · strength 0.50
  23. Caitlin A. Hester · 2 shared papers, 2024 · strength 0.39
  24. Mary P Martos · 2 shared papers, 2024 · strength 0.39
  25. Supriya Srinivasan · 2 shared papers, 2025 · strength 0.38

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.